ArticleNeuro-oncology2022

Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.

E Antonio Chiocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.